arrow
E

Elizabeth Stewart

St Jude Children's Research Hospital
H指数:25
被引数:2,477

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Prioritization of novel agents for further investigation in pediatric non-rhabdomyosarcoma soft tissue sarcomas: A report from the Children’s Oncology Group

新型药物在儿童非横纹肌肉瘤软组织肉瘤中的优先级排序及进一步研究的报告:来自儿童肿瘤组的报告

2025-07-060
PRE
Roadmap for the next generation of Children's Oncology Group rhabdomyosarcoma trials
CANCER
IF5.1
2024-06-280
PRE
Targeting DCAF5 suppresses SMARCB1-mutant cancer by stabilizing SWI/SNF
Nature
IF48.5
2024-03-270
PRE
DNAJB1-PRKACA fusion neoantigens elicit rare endogenous T cell responses that potentiate cell therapy for fibrolamellar carcinoma
2024-03-010
OAAI
Paediatric Strategy Forum for medicinal product development of DNA damage response pathway inhibitors in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration
2023-09-016
OAAI
Ontology guided navigation of somatic variants, mutational signatures, gene expression and histology images for pediatric cancer
2023-04-040
PRE
Alzheimer's disease-associated U1 snRNP splicing dysfunction causes neuronal hyperexcitability and cognitive impairment
2022-10-1220
OA
The myogenesis program drives clonal selection and resistance in

肌生成程序驱动克隆选择和抗性

2022-05-0128
OA
The chemotherapeutic CX-5461 primarily targets TOP2B and exhibits selective activity in high-risk neuroblastoma
2021-11-0944
OAAI
SLFN11 is Widely Expressed in Pediatric Sarcoma and Induces Variable Sensitization to Replicative Stress Caused By DNA-Damaging Agents
2021-08-1911
OA
Retinoblastoma from human stem cell-derived retinal organoids

来自人类干细胞衍生的视网膜类器官的视网膜母细胞瘤

2021-07-2763
OAAI
Prioritization of Novel Agents for Patients with Rhabdomyosarcoma: A Report from the Children's Oncology Group (COG) New Agents for Rhabdomyosarcoma Task Force
2021-04-0115
OAAI
MYCN amplification and ATRX mutations are incompatible in neuroblastoma

MYCN扩增和ATRX突变在神经母细胞瘤中不相容

2020-02-1477
OAAI